Navigation Links
Mayo Clinic identifies new risk factor for heart attack patients
Date:11/5/2007

ORLANDO, Fla. -- If you go to the hospital within one to two hours of the onset of symptoms of a heart attack, your chances of getting proper treatment are nearly 70 percent greater than those who wait 11 to 12 hours before seeking treatment, according to results presented today at the American Heart Associations Scientific Sessions 2007 in Orlando, Fla.

This research should emphasize to patients that getting help immediately, by calling 911, gives them the best chance of receiving treatments we know can help save their lives or lessen the damage to their hearts, says Henry Ting, M.D., lead Mayo Clinic cardiovascular researcher on the national study. If patients wait at home for hours with symptoms and come in later, unfortunately they arent getting the proper treatments.

The most serious type of heart attack is known as an ST-elevation myocardial infarction (STEMI). In a STEMI, critical arteries supplying the heart with blood are blocked. Previous studies have shown that the best treatment for STEMI patients is reperfusion therapy -- when a patients blocked artery is opened by inflating a balloon at the site of the blockage or by delivering clot-dissolving medication, thus restoring blood flow to heart muscle.

Significance of the Mayo Clinic Research

The study is the largest and most detailed review of multiple elements in patient records contained in a national heart attack database. These elements are: time delay from onset of symptoms to hospital arrival; treatment with reperfusion; and treatment outcome. After analyzing 440,398 heart attack incidents from 1995 to 2004 in the National Registry of Myocardial Infarction, the researchers identify for the first time a novel risk factor for heart attack deaths that appears to have a readily available solution: comply with the American Heart Association/American Cardiology Association guidelines now in place. The guidelines state that if a patient has symptoms consistent with a heart attack which are not relieved after five minutes, or after placing one nitroglycerin pill under the tongue, the patient should call 911.

About the Study

The records that the team reviewed document how long it took for 440,398 heart attack patients to arrive at the hospital after their symptoms started, and correlate arrival time with the rates of reperfusion therapy they received upon arriving at the hospital.

Results show that:

  • Of patients who arrived at the hospital within one to two hours of onset of heart attack, 77 percent received reperfusion therapy.

  • Of patients who arrived at the hospital within two to three hours of onset of heart attack, 73 percent received reperfusion therapy.

  • Of patients who arrived at the hospital within 11 to 12 hours of onset of heart attack, only 46 percent of patients received reperfusion therapy.

Although current guidelines recommend that STEMI patients who reach the hospital within 12 hours after their symptoms started should receive reperfusion therapy, we found that this is not happening, Dr. Ting says. These delays represent a novel and modifiable risk factor and warrant further investigation. These results show that gaps remain in quality of care in patients with STEMI -- first, we need to encourage patients with potential heart attacks to come to the hospital as early as possible; second, hospitals need to implement systems that treat all eligible patients rapidly regardless of the delay in presentation.


'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Radiologists encouraged to look beyond cancer for clinically unseen diseases
3. Clinical depression linked to abnormal emotional brain circuits
4. Preclinical study suggests organ-transplant drug may aid in lupus fight
5. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
6. AASM encourages those student-athletes at risk for developing osa to visit a sleep clinic
7. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
8. MinuteClinic Becomes Participating Provider with Assurant Health
9. Therap Services Continues to Hire Experienced Developmental Disability Industry Clinicians for its Customer Support Team
10. Acupuncturists Relocation Tightens Relationship With Fertility Clinic
11. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... Overland Park, KS (PRWEB) , ... June 27, 2016 , ... ... leader in retailers of Eyeglasses . , Millions of individuals in the United ... life, eyeglasses have become a way to both correct vision and make a fashion ...
(Date:6/26/2016)... , ... June 26, 2016 , ... PawPaws brand ... new product that was developed to enhance the health of felines. The formula is ... The two main herbs in the PawPaws Cat Kidney Support Supplement Soft ...
(Date:6/25/2016)... ... , ... Austin residents seeking Mohs surgery services, can now turn to Dr. ... Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include ... in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: